- UHRA Home
- Browsing by Author
Browsing by Author "Almond, Michael"
Now showing items 1-7 of 7
-
Antidepressant Usage in Haemodialysis Patients: Evidence of Sub-optimal Practice Patterns
Guirguis, Ayman; Almond, Michael; Chilcot, Joseph; Davenport, A.; Wellsted, David; Farrington, Kenneth (2020-06-01)Background: Depression is common in patients on haemodialysis and associated with adverse outcomes. Antidepressant use is widespread though evidence of efficacy is limited. Objectives: To study antidepressant management ... -
Indexing dialysis dose for gender, body size and physical activity: Impact on survival
Sridharan, Sivakumar; Vilar Hall, Enric; Davenport, Andrew; Ashman, Neil; Almond, Michael; Banerjee, Anindya; Justin, Roberts,; Farrington, Kenneth (2018-09-07)Current practice basing dialysis dose on urea distribution volume (V) has been questioned. We explored the impact on survival of scaling dialysis dose (Kt) to parameters reflective of metabolic activity. In a multicentre ... -
Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scores
Davenport, Andrew; Guirguis, Ayman; Almond, Michael; Day, Clara; Chilcot, Joseph; Da Silva Gane, Maria; Fineberg, Naomi; Friedl, Karin; Spencer, Benjamin; Wellsted, David; Farrington, Ken (2018-07-01)Introduction: Most patients take time to recover after a hemodialysis (HD) session. It has been suggested that recovery time is associated with intradialytic hypotension and rapid solute clearances. Other studies have ... -
Scaling Hemodialysis Target Dose to Reflect Body Surface Area, Metabolic Activity, and Protein Catabolic Rate : A Prospective, Cross-sectional Study
Sridharan, Sivakumar; Vilar, Enric; Davenport, Andrew; Ashman, Neil; Almond, Michael; Banerjee, Anindya; Roberts, Justin; Farrington, Kenneth (2017-03-01)BACKGROUND: Women and small men treated by hemodialysis (HD) have reduced survival. This may be due to use of total-body water (V) as the normalizing factor for dialysis dosing. In this study, we explored the equivalent ... -
Self-reported depression symptoms in haemodialysis patients: Bi-factor structures of two common measures and their association with clinical factors
Farrington, Kenneth; Chilcot, Joseph; Almond, Michael; Guirguis, ayman; Friedli, karin; Day, Clara; Davenport, Andrew; Wellsted, David (2018-09)Objective: To validate the factor structure of two common self-report depression tools in a large sample of haemodialysis (HD) patients and to examine their demographic and clinical correlates, including urine output, ... -
Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis : A Randomized, Controlled Feasibility Trial
Friedli, Karin; Guirguis, Ayman; Almond, Michael; Day, Clara; Chilcot, Joseph; Da Silva-Gane, Maria; Davenport, Andrew; Fineberg, Naomi A; Spencer, Benjamin; Wellsted, David; Farrington, Ken (2017-02-07)BACKGROUND AND OBJECTIVES: Depression is common in patients on hemodialysis, but data on the benefits and risks of antidepressants in this setting are limited. We conducted a multicenter, randomized, double-blind, ... -
A study of sertraline in dialysis (ASSertID) : a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis
Friedli, Karin; Almond, Michael; Day, Clara; Chilcot, Joseph; Gane, Maria da Silva; Davenport, Andrew; Guirguis, Ayman; Fineberg, Naomi; Spencer, Benjamin; Wellsted, D.; Farrington, Ken (2015-10-26)BACKGROUND: The prevalence of depression in people receiving haemodialysis is high with estimates varying between 20 and 40 %. There is little research on the effectiveness of antidepressants in dialysis patients with the ...